These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22036037)

  • 1. Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia.
    Eggan SM; Lazarus MS; Stoyak SR; Volk DW; Glausier JR; Huang ZJ; Lewis DA
    Biol Psychiatry; 2012 Jan; 71(2):114-9. PubMed ID: 22036037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.
    Eggan SM; Hashimoto T; Lewis DA
    Arch Gen Psychiatry; 2008 Jul; 65(7):772-84. PubMed ID: 18606950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
    Akbarian S; Kim JJ; Potkin SG; Hagman JO; Tafazzoli A; Bunney WE; Jones EG
    Arch Gen Psychiatry; 1995 Apr; 52(4):258-66. PubMed ID: 7702443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.
    Gomes FV; Edelson JR; Volk DW; Grace AA
    Schizophr Res; 2018 Nov; 201():254-260. PubMed ID: 29705007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
    Woo TU; Walsh JP; Benes FM
    Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.
    Volk DW; Austin MC; Pierri JN; Sampson AR; Lewis DA
    Arch Gen Psychiatry; 2000 Mar; 57(3):237-45. PubMed ID: 10711910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF Val66Met polymorphism and GAD67 mRNA expression in the prefrontal cortex of subjects with schizophrenia.
    Hashimoto T; Lewis DA
    Am J Psychiatry; 2006 Mar; 163(3):534-7. PubMed ID: 16513879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.
    Georgiev D; Yoshihara T; Kawabata R; Matsubara T; Tsubomoto M; Minabe Y; Lewis DA; Hashimoto T
    Schizophr Bull; 2016 Jul; 42(4):992-1002. PubMed ID: 26980143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.
    Volk DW; Eggan SM; Horti AG; Wong DF; Lewis DA
    Schizophr Res; 2014 Oct; 159(1):124-9. PubMed ID: 25107849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
    Volk D; Austin M; Pierri J; Sampson A; Lewis D
    Am J Psychiatry; 2001 Feb; 158(2):256-65. PubMed ID: 11156808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.
    Heckers S; Stone D; Walsh J; Shick J; Koul P; Benes FM
    Arch Gen Psychiatry; 2002 Jun; 59(6):521-9. PubMed ID: 12044194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.
    Curley AA; Arion D; Volk DW; Asafu-Adjei JK; Sampson AR; Fish KN; Lewis DA
    Am J Psychiatry; 2011 Sep; 168(9):921-9. PubMed ID: 21632647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.
    Akbarian S; Huntsman MM; Kim JJ; Tafazzoli A; Potkin SG; Bunney WE; Jones EG
    Cereb Cortex; 1995; 5(6):550-60. PubMed ID: 8590827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.
    Hashimoto T; Volk DW; Eggan SM; Mirnics K; Pierri JN; Sun Z; Sampson AR; Lewis DA
    J Neurosci; 2003 Jul; 23(15):6315-26. PubMed ID: 12867516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia.
    Maldonado-Avilés JG; Curley AA; Hashimoto T; Morrow AL; Ramsey AJ; O'Donnell P; Volk DW; Lewis DA
    Am J Psychiatry; 2009 Apr; 166(4):450-9. PubMed ID: 19289452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia.
    Volk DW; Lewis DA
    Biol Psychiatry; 2016 Apr; 79(7):595-603. PubMed ID: 26210060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268.
    Kimoto S; Bazmi HH; Lewis DA
    Am J Psychiatry; 2014 Sep; 171(9):969-78. PubMed ID: 24874453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
    Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
    Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.
    Hashimoto T; Arion D; Unger T; Maldonado-Avilés JG; Morris HM; Volk DW; Mirnics K; Lewis DA
    Mol Psychiatry; 2008 Feb; 13(2):147-61. PubMed ID: 17471287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.
    Eggan SM; Stoyak SR; Verrico CD; Lewis DA
    Neuropsychopharmacology; 2010 Sep; 35(10):2060-71. PubMed ID: 20555313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.